Does AMIVANTAMAB-VMJW Cause Pleural effusion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Pleural effusion have been filed in association with AMIVANTAMAB-VMJW. This represents 0.3% of all adverse event reports for AMIVANTAMAB-VMJW.
5
Reports of Pleural effusion with AMIVANTAMAB-VMJW
0.3%
of all AMIVANTAMAB-VMJW reports
1
Deaths
3
Hospitalizations
How Dangerous Is Pleural effusion From AMIVANTAMAB-VMJW?
Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB-VMJW. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB-VMJW Cause?
Infusion related reaction (509)
Rash (315)
Off label use (130)
Dyspnoea (81)
Paronychia (78)
Nausea (65)
Oxygen saturation decreased (55)
Flushing (54)
Death (53)
Non-small cell lung cancer (51)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which AMIVANTAMAB-VMJW Alternatives Have Lower Pleural effusion Risk?
AMIVANTAMAB-VMJW vs AMLODIPINE
AMIVANTAMAB-VMJW vs AMLODIPINE BESILATE
AMIVANTAMAB-VMJW vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB-VMJW vs AMLODIPINE\BENAZEPRIL
AMIVANTAMAB-VMJW vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN